Baicalin, baicalein and wogonin inhibits high glucose-induced vascular inflammation in vitro and in vivo

BMB Reports

Volumn 48, Issue 9, 2015, Pages 519-524

  Ku, Sae Kwang ^a   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Baicalein; Baicalin; Diabetes mellitus; High glucose; Wogonin

Indexed keywords

BAICALEIN; BAICALIN; CELL ADHESION MOLECULE; FLAVANONE DERIVATIVE; FLAVONOID; GLUCOSE; HERBACEOUS AGENT; HUANG QI; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; REACTIVE OXYGEN METABOLITE; WOGONIN;

ANIMAL; DIABETES COMPLICATIONS; HUMAN; INFLAMMATION; METABOLISM; MOUSE; PATHOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION MOLECULES; DIABETES COMPLICATIONS; DRUGS, CHINESE HERBAL; FLAVANONES; FLAVONOIDS; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MICE; NF-KAPPA B; REACTIVE OXYGEN SPECIES; VASCULITIS;

EID: 84944733950     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.9.017     Document Type: Article

References (30)

1. Whiting DR, Guariguata L, Weil C and Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94, 311-321
2. Grundy SM, Benjamin IJ, Burke GL et al (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134-1146
3. Thomas JE and Foody JM (2007) The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy. J Cardiometab Syndr 2, 108-113
4. Roglic G, Unwin N, Bennett PH et al (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28, 2130-2135
5. Rubino F and Gagner M (2002) Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236, 554-559
6. Li GQ, Kam A, Wong KH et al (2012) Herbal medicines for the management of diabetes. Adv Exp Med Biol 771, 396-413
7. Day C (1998) Traditional plant treatments for diabetes mellitus: pharmaceutical foods. Br J Nutr 80, 5-6
8. Kubo M, Asano T, Shiomoto H and Matsuda H (1994) Studies on rehmanniae radix. I. Effect of 50% ethanolic extract from steamed and dried rehmanniae radix on hemorheology in arthritic and thrombosic rats. Biol Pharm Bull 17, 1282-1286
9. Kubo M, Matsuda H, Tanaka M et al (1984) Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem Pharm Bull (Tokyo) 32, 2724-2729
10. Chen YC, Shen SC, Chen LG, Lee TJ and Yang LL (2001) Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 61, 1417-1427
11. Chiu JH, Lay IS, Su MY et al (2002) Tumor necrosis factor-producing activity of wogonin in RAW 264.7 murine macrophage cell line. Planta Med 68, 1036-1039
12. Laakso M (1999) Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48, 937-942
13. Kannel WB and McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 2035-2038
14. Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G and Navalesi R (1995) Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 18, 1-9
15. Wardle EN (1994) Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract 23, 135-139
16. Tooke JE (1995) Microvascular function in human diabetes. A physiological perspective. Diabetes 44, 721-726
17. Gerrity RG (1981) The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103, 181-190
18. Esposito C, Fasoli G, Plati AR et al (2001) Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney Int 59, 1842-1849
19. Hamuro M, Polan J, Natarajan M and Mohan S (2002) High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 162, 277-287
20. Morigi M, Angioletti S, Imberti B et al (1998) Leukocyteendothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 101, 1905-1915
21. Lopes-Virella MF and Virella G (1992) Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41 Suppl 2, 86-91
22. Bae JS (2012) Role of high mobility group box 1 in inflammatory disease: Focus on sepsis. Arch Pharm Res 35, 1511-1523
23. Kado S, Wakatsuki T, Yamamoto M and Nagata N (2001) Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sci 68, 727-737
24. Hansson GK and Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6, 508-519
25. Boisvert WA (2004) Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14, 161-165
26. Inoguchi T, Li P, Umeda F et al (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939-1945
27. Dunlop M (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77, S3-12
28. Han HJ, Lee YJ, Park SH, Lee JH and Taub M (2005) High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 288, F988-996
29. Rimbach G, Valacchi G, Canali R and Virgili F (2000) Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun 3, 238-242
30. Uemura S, Matsushita H, Li W et al (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88, 1291-1298